Back to search
FDAFDA · Food and drugs·Recall number D-0723-2022

Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30

Published March 30, 2022 · Recall initiated: March 8, 2022

Summary

FDA records drug Class III recall D-0723-2022, published March 30, 2022 and initiated March 8, 2022. Recalling firm: Olympia Compounding Pharmacy dba Olympia Pharmacy; Status: Terminated; Reported quantity: 1613 vials; Lot: Lot: E47025 Exp. 5/21/22. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub Potent

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympia Compounding Pharmacy dba Olympia Pharmacy
Distributor
Nationwide in the USA including Puerto Rico.
Lot
Lot: E47025 Exp. 5/21/22
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxocobalamin B12 1mg/mL, Multi-Dose 30 mL vial, Each ML contains: 0.82% Sodium Chloride USP, 0.9% Benzyl Alcohol NF, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals Conroy Rd., Ste. 155, Orlando, FL 32835 NDC 73198-0080-30 recalled?

Yes. FDA published recall D-0723-2022 on March 30, 2022. Reported hazard: Sub Potent

What should I do if I have this product?

Voluntary: Firm initiated · Letter